Effects of the antimicrobial peptide LL-37 and hyperthermic preconditioning in septic rats

Anesthesiology

Volumn 107, Issue 3, 2007, Pages 437-441

  Torossian, Alexander ^a,d   Gurschi, Eugeniu ^a   Bals, Robert ^b   Vassiliou, Timon ^a   Wulf, Hinnerk F ^a   Bauhofer, Artur ^b,c  

^a Department of Anesthesia and Critical Care ^*

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

^c VIATRIS GmbH and Co KG   (Germany)

^d UNIVERSITY HOSPITAL MARBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; HEAT SHOCK PROTEIN 70; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 2; TUMOR NECROSIS FACTOR ALPHA;

ABDOMINAL INFECTION; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; IMMUNE RESPONSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEPSIS;

ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; DISEASE MODELS, ANIMAL; FECES; GRANULOCYTES; HSP70 HEAT-SHOCK PROTEINS; HYPERTHERMIA, INDUCED; INTERLEUKIN-6; LEUKOCYTES; MALE; MONOKINES; NEUTROPHILS; PERITONITIS; PHAGOCYTOSIS; RATS; RATS, WISTAR; SEPSIS; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34548209277     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/01.anes.0000278906.86815.eb     Document Type: Article

References (34)

1. Zanetti M, Gennaro R, Romeo D: Cathelicidins: A novel protein family with a common proregion and a variable C-terminal antimicrobial domain. FEBS Lett 1995; 374:1-5
2. Agerberth B, Gunne H, Odeberg J, Kogner P, Boman HG, Gudmundsson GH: FALL-39, a putative human peptide antibiotic, is cysteine-free and expressed in bone marrow and testis. Proc Natl Acad Sci U S A 1995; 92:195-9
3. Agerberth B, Charo J, Werr J, Olsson B, Idali F, Lindbom L, Kiessling R, Jornvall H, Wigzell H, Gudmundsson GH: The human antimicrobial and chemotactic peptides LL-37 and alpha-defensins are expressed by specific lymphocyte and monocyte populations. Blood 2000; 96:3086-93
4. Dorschner RA, Pestonjamasp VK, Tamakuwala S, Ohtake T, Rudisill J, Nizet V, Agerberth B, Gudmundsson GH, Gallo RL: Cutaneous injury induces the release of cathelicidin anti-microbial peptides active against group A Streptococcus. J Invest Dermatol 2001; 117:91-7
5. Nilsson MF, Sandstedt B, Sorensen O, Weber G, Borregaad N, Stahle-Backdahl M: The human cationic antimicrobial protein (hCAP18), a peptide antibiotic, is widely expressed in human squamous epithelia and colocalizes with interleukin-6. Infect Immun 1999; 67:2561-6
6. Durr UH, Sudheendra US, Ramamoorthy A: LL-37, the only human member of the cathelicidin family of antimicrobial peptides. Biochim Biophys Acta 2006; 1758:1408-25
7. Cirioni O, Giacometti A, Ghiselli R, Bergnach C, Orlando F, Silvestri C, Mocchegiani F, Licci A, Skerlavaj B, Rocchi M, Saba V, Zanetti M, Scalise G: LL-37 protects rats against lethal sepsis caused by gram-negative bacteria. Antimicrob Agents Chemother 2006; 50:1672-9
8. Shaykhiev R, Beisswenger C, Kandler K, Senske J, Puchner A, Damm T, Behr J, Bals R: Human endogenous antibiotic LL-37 stimulates airway epithelial cell proliferation and wound closure. Am J Physiol Lung Cell Mol Physiol 2005; 289:842-8
9. Tjabringa GS, Rabe KF, Hiemstra PS: The human cathelicidin LL-37: A multifunctional peptide involved in infection and inflammation in the lung. Pulm Pharmacol Ther 2005; 18:321-7
10. Heilborn JD, Nilsson MF, Kratz G, Weber G, Sorensen O, Borregaard N, Stahle-Backdahl M: The cathelicidin anti-microbial peptide LL-37 is involved in re-epithelialization of human skin wounds and is lacking in chronic ulcer epithelium. J Invest Dermatol 2003; 120:379-89
11. Lee PH, Ohtake T, Zaiou M, Murakami M, Rudisill JA, Lin KH, Gallo RL: Expression of an additional cathelicidin antimicrobial peptide protects against bacterial skin infection. Proc Natl Acad Sci U S A 2005; 102:3750-5
12. Bals R, Weiner DJ, Moscioni AD, Meegalla RL, Wilson JM: Augmentation of innate host defense by expression of a cathelicidin antimicrobial peptide. Infect Immun 1999; 67:6084-9
13. Gulluoglu BM, Aksoy BS, Ozveri ES, Yuksel M, Demiralp EE, Aktan AO: Optimal timing and temperature for hyperthermic preconditioning in an animal model of fecal peritonitis. J Invest Surg 2002; 15:117-24
14. Hotchkiss R, Nunnally I, Lindquist S, Taulien J, Perdrizet G, Karl I: Hyperthermia protects mice against the lethal effects of endotoxin. Am J Physiol 1993; 265:1447-57
15. Koh Y, Lim CM, Kim MJ, Shim TS, Lee SD, Kim WS, Kim DS, Kim WD: Heat shock response decreases endotoxin-induced acute lung injury in rats. Respirology 1999; 4:325-30
16. Villar J, Ribeiro SP, Mullen JB, Kuliszewski M, Post M, Slutsky AS: Induction of the heat shock response reduces mortality rate and organ damage in a sepsis-induced acute lung injury model. Crit Care Med 1994; 22:914-21
17. Chen HW, Hsu C, Lue SI, Yang RC: Attenuation of sepsis-induced apoptosis by heat shock pretreatment in rats. Cell Stress Chaperones 2000; 5:188-95
18. Chen Q, Fisher DT, Kucinska SA, Wang WC, Evans SS: Dynamic control of lymphocyte trafficking by fever-range thermal stress. Cancer Immunol Immunother 2006; 55:299-311
19. Bauhofer A, Torossian A, Lorenz W, Middeke M, Plaul U, Schutz P, Stinner B, Huttel M, Celik I: Dependence of positive effects of granulocyte colony-stimulating factor on the antibiotic regimen: Evaluation in rats with polymicrobial peritonitis. World J Surg 2004; 28:834-44
20. Friedman LM, Furberg CD, DeMets DL: Fundamentals of Clinical Trials, 2nd edition. Littleton, Massachusetts, PSG Publishing, 1985
21. Bals R, Wilson JM: Cathelicidins: A family of multifunctional antimicrobial peptides. Cell Mol Life Sci 2003; 60:711-20
22. Wang Y, Agerberth B, Lothgren A, Almstedt A, Johansson J: Apolipoprotein A-I binds and inhibits the human antibacterial/cytotoxic peptide LL-37. J Biol Chem 1998; 273:33115-8
23. Wang Y, Johansson J, Agerberth B, Jornvall H, Griffiths WJ: The antimicrobial peptide LL-37 binds to the human plasma protein apolipoprotein A-I. Rapid Commun Mass Spectrom 2004; 18:588-9
24. Singleton KD, Wischmeyer PE: Distance of cecum ligated influences mortality, tumor necrosis factor-alpha and interleukin-6 expression following cecal ligation and puncture in the rat. Eur Surg Res 2003; 35:486-91
25. Ostberg JR, Kaplan KC, Repasky EA: Induction of stress proteins in a panel of mouse tissues by fever-range whole body hyperthermia. Int J Hyperthermia 2002; 18:552-62
26. Pollheimer J, Zellner M, Eliasen MM, Roth E, Oehler R: Increased susceptibility of glutamine-depleted monocytes to fever-range hyperthermia: The role of 70-kDa heat shock protein. Ann Surg 2005; 241:349-55
27. Blake D, Bessey P, Karl I, Nunnally I, Hotchkiss R: Hyperthermia induces IL-1 alpha but does not decrease release of IL-1 alpha or TNF-alpha after endotoxin. Lymphokine Cytokine Res 1994; 13:271-5
28. Dong HP, Chen HW, Hsu C, Chiu HY, Lin LC, Yang RC: Previous heat shock treatment attenuates lipopolysaccharide-induced hyporesponsiveness of platelets in rats. Shock 2005; 24:239-44
29. Ostberg JR, Ertel BR, Lanphere JA: An important role for granulocytes in the thermal regulation of colon tumor growth. Immunol Invest 2005; 34:259-72
30. Kraybill WG, Olenki T, Evans SS, Ostberg JR, O'Leary KA, Gibbs JF, Repasky EA: A phase I study of fever-range whole body hyperthermia (FR-WBH) in patients with advanced solid tumours: Correlation with mouse models. Int J Hyperthermia 2002; 18:253-66
31. Hegewisch-Becker S, Gruber Y, Corovic A, Pichlmeier U, Atanackovic D, Nierhaus A, Hossfeld DK: Whole-body hyperthermia (41.8 degrees C) combined with bimonthly oxaliplatin, high-dose leucovorin and 5-fluorouracil 48-hour continuous infusion in pretreated metastatic colorectal cancer: A phase II study. Ann Oncol 2002; 13:1197-204
32. De Roover A, Detroz B, Detry O, Coimbra C, Polus M, Belaiche J, Meurisse M, Honore P: Adjuvant hyperthermic intraperitoneal peroperative chemotherapy (HIPEC) associated with curative surgery for locally advanced gastric carcinoma: An initial experience. Acta Chir Belg 2006; 106:297-301
33. Lopez M, Sessler DI, Walter K, Emerick T, Ozaki M: Rate and gender dependence of the sweating, vasoconstriction and shivering thresholds in humans. ANESTHESIOLOGY 1994; 80:780-8
34. L'Her E, Amerand A, Vettier A, Sebert P: Effects of mild induced hypothermia during experimental sepsis. Crit Care Med 2006; 34:2621-3